Company Filing History:
Years Active: 2009
Title: The Innovative Contributions of Stefano Cagnani
Introduction
Stefano Cagnani is a notable inventor based in Settima Di Gossolengo, Italy. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative drug delivery systems. His work focuses on creating highly respirable microparticles for therapeutic agents, which can enhance the efficacy of treatments.
Latest Patents
Cagnani holds a patent for "Insulin Highly Respirable Microparticles." This invention describes novel dried powders of peptide therapeutic agents that are useful for producing highly respirable aerosols. The preferred embodiment of this invention is insulin, which is a critical therapeutic agent for diabetes management. The powders are characterized by their unique structure and shape, allowing for easy aerosolization. The typical dry powder of insulin exhibits corrugated, non-agglomerated microparticles with a low tapped density. The mean geometric diameter of these particles ranges between 1.0 and 10.0 microns, while the mass median aerodynamic diameter (MMAD) ranges between 1.0 and 4.0 microns. These insulin pulmonary powders demonstrate a very high respirable fraction of over 75% in vitro.
Career Highlights
Stefano Cagnani is affiliated with the University of Parma, where he conducts research and development in pharmaceutical sciences. His innovative work has positioned him as a key figure in the advancement of drug delivery technologies.
Collaborations
Cagnani has collaborated with notable colleagues, including Paolo Colombo and Paolo Ventura. Their combined expertise has contributed to the success of various research projects and innovations in the field.
Conclusion
Stefano Cagnani's contributions to the development of highly respirable insulin microparticles represent a significant advancement in pharmaceutical technology. His innovative approach has the potential to improve the delivery and efficacy of therapeutic agents, making a lasting impact on patient care.